1. Introduction
The nervous system is a complex network comprising the central nervous system (CNS) — brain and spinal cord — and the peripheral nervous system (PNS) — cranial and spinal nerves. It coordinates sensory input, motor output, and autonomic functions, maintaining homeostasis and enabling interaction with the environment.
Nervous system disorders represent a broad group of conditions that impair structure and function, leading to cognitive, sensory, motor, and autonomic dysfunction. These include neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s), demyelinating disorders (e.g., multiple sclerosis), cerebrovascular disorders (stroke), peripheral neuropathies, and traumatic brain or spinal cord injuries.
Understanding their pathophysiology provides insight into disease progression, therapeutic targets, and rehabilitation strategies.
2. Normal Nervous System Structure and Function
2.1 Central Nervous System (CNS)
- Brain: Composed of cerebrum, cerebellum, brainstem.
- Controls cognition, motor function, sensory processing, autonomic regulation.
- Spinal Cord: Transmits motor and sensory signals, mediates reflexes.
2.2 Peripheral Nervous System (PNS)
- Cranial and Spinal Nerves: Carry motor, sensory, and autonomic signals to and from CNS.
- Autonomic Nervous System (ANS): Sympathetic and parasympathetic divisions maintain homeostasis.
2.3 Cellular Components
- Neurons: Functional units transmitting electrical impulses via axons and dendrites.
- Glial Cells: Astrocytes, oligodendrocytes, microglia, and Schwann cells provide structural support, myelination, and immune surveillance.
- Synapses: Specialized junctions for neurotransmitter-mediated communication.
3. General Pathophysiological Mechanisms in Nervous System Disorders
The nervous system is vulnerable to multiple pathological processes:
- Neuronal injury and death: Apoptosis or necrosis due to ischemia, toxins, or genetic mutations.
- Demyelination: Loss of myelin sheath impairs nerve conduction.
- Neuroinflammation: Activation of microglia and astrocytes releases cytokines and reactive oxygen species (ROS).
- Excitotoxicity: Excess glutamate causes calcium overload → neuronal death.
- Protein misfolding and aggregation: Impairs synaptic function and triggers neurodegeneration.
- Vascular compromise: Reduced perfusion leads to ischemic injury (stroke).
- Peripheral nerve degeneration: Axonal loss and demyelination impair motor and sensory function.
4. Pathophysiology of Selected Nervous System Disorders
4.1 Neurodegenerative Disorders
4.1.1 Alzheimer’s Disease (AD)
Definition: Progressive neurodegenerative disorder causing memory loss and cognitive decline.
Pathophysiology:
- Amyloid-beta accumulation: Extracellular plaques impair synaptic function.
- Tau protein hyperphosphorylation: Intracellular neurofibrillary tangles disrupt axonal transport.
- Neuroinflammation: Microglial activation releases cytokines → neuronal death.
- Cholinergic deficit: Loss of acetylcholine-producing neurons → memory and learning impairment.
Clinical Features: Progressive memory loss, disorientation, cognitive dysfunction, behavioural changes.
4.1.2 Parkinson’s Disease (PD)
Definition: Neurodegenerative disorder primarily affecting motor function.
Pathophysiology:
- Degeneration of dopaminergic neurons in substantia nigra pars compacta → reduced striatal dopamine.
- Imbalance between dopaminergic and cholinergic pathways → motor symptoms.
- Lewy body formation (alpha-synuclein aggregates) → further neuronal dysfunction.
Clinical Features: Bradykinesia, resting tremor, rigidity, postural instability, autonomic dysfunction.
4.2 Demyelinating Disorders
4.2.1 Multiple Sclerosis (MS)
Definition: Autoimmune-mediated demyelination of CNS axons.
Pathophysiology:
- Autoreactive T cells cross the blood–brain barrier → attack myelin and oligodendrocytes.
- Inflammatory cytokines promote demyelination and axonal injury.
- Formation of plaques (sclerotic lesions) in white matter.
- Impaired nerve conduction → sensory, motor, and autonomic deficits.
Clinical Features: Weakness, spasticity, sensory loss, vision changes, fatigue.
4.3 Cerebrovascular Disorders
4.3.1 Stroke (Ischemic and Haemorrhagic)
Definition: Acute neurological deficit due to vascular compromise.
Ischemic Stroke Pathophysiology:
- Arterial occlusion → decreased cerebral perfusion → hypoxia.
- Neurons switch to anaerobic metabolism → lactic acidosis.
- Excitotoxicity: Excess glutamate → intracellular calcium overload → apoptosis/necrosis.
- Inflammatory response exacerbates tissue injury.
Hemorrhagic Stroke Pathophysiology:
- Vessel rupture → hematoma formation → mass effect and increased intracranial pressure.
- Secondary ischemia due to disrupted perfusion.
Clinical Features: Sudden weakness, sensory deficits, speech disturbance, altered consciousness.
4.4 Peripheral Neuropathies
Definition: Disorders affecting peripheral nerves, causing motor, sensory, or autonomic dysfunction.
Pathophysiology:
- Diabetic neuropathy: Chronic hyperglycemia → oxidative stress, microvascular injury, axonal degeneration.
- Guillain-Barré Syndrome (GBS): Autoimmune attack on peripheral myelin → acute flaccid paralysis.
- Compression neuropathies: Mechanical compression → ischemia and demyelination (e.g., carpal tunnel syndrome).
Clinical Features: Pain, paresthesia, muscle weakness, reflex changes.
4.5 Spinal Cord Injury (SCI)
Definition: Acute or chronic damage to the spinal cord, resulting in motor, sensory, and autonomic deficits.
Pathophysiology:
- Primary injury: Mechanical trauma damages neurons, axons, and vasculature.
- Secondary injury: Ischemia, excitotoxicity, oxidative stress, and inflammation exacerbate cell death.
- Glial scar formation: Impedes axonal regeneration.
Clinical Features: Paralysis (tetraplegia or paraplegia), sensory loss, autonomic dysfunction, spasticity.
4.6 Epilepsy
Definition: Chronic neurological disorder characterized by recurrent, unprovoked seizures.
Pathophysiology:
- Abnormal neuronal excitability: Ion channel mutations or imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission.
- Hyper-synchronous neuronal firing → seizures.
- Structural lesions (tumors, cortical dysplasia) or metabolic disturbances may trigger seizures.
Clinical Features: Motor convulsions, sensory phenomena, altered consciousness, autonomic symptoms.
4.7 Neuroinflammatory Disorders
Meningitis and Encephalitis
- Bacterial, viral, or autoimmune inflammation of meninges or brain parenchyma.
- Inflammatory cytokines increase blood–brain barrier permeability, edema, and neuronal injury.
- May result in chronic neurological deficits or death if untreated.
5. Cellular and Molecular Mechanisms
- Excitotoxicity: Excess glutamate → calcium influx → mitochondrial dysfunction → apoptosis.
- Oxidative Stress: ROS and nitrogen species damage lipids, proteins, and DNA.
- Protein Misfolding: Aggregates of tau, amyloid, or alpha-synuclein impair synaptic and axonal function.
- Neuroinflammation: Microglial and astrocyte activation release pro-inflammatory cytokines (IL-1β, TNF-α, IL-6).
- Demyelination: Loss of oligodendrocytes (CNS) or Schwann cells (PNS) → slowed conduction and conduction block.
- Neurovascular compromise: Reduced blood flow → ischemia and neuronal death.
6. Systemic and Functional Consequences
- Cognitive Impairment: Memory loss, executive dysfunction, disorientation.
- Motor Dysfunction: Weakness, paralysis, spasticity, ataxia.
- Sensory Deficits: Paresthesia, numbness, loss of proprioception.
- Autonomic Dysfunction: Cardiovascular instability, bowel/bladder control issues.
- Psychological Impact: Anxiety, depression, social isolation.
7. Integrative and Yoga-Based Perspectives
From a holistic perspective, nervous system disorders often involve stress, autonomic imbalance, and musculoskeletal tension, in addition to structural pathology.
Yoga Therapy Interventions
- Asanas: Improve circulation, neural alignment, and flexibility (e.g., Tadasana, Bhujangasana).
- Pranayama: Enhances parasympathetic tone, reduces stress hormones, and supports neuroplasticity (e.g., Nadi Shodhana).
- Meditation and Mindfulness: Reduce anxiety, enhance cognitive function, and modulate pain perception.
- Lifestyle Management: Adequate sleep, balanced nutrition, and ergonomics reduce neural stress and optimize CNS/PNS function.
Research indicates yoga and mind–body interventions support neuroplasticity, reduce inflammation, and improve functional outcomes in neurological disorders such as stroke, multiple sclerosis, Parkinson’s disease, and chronic neuropathic pain.
8. Conclusion
Nervous system disorders encompass a diverse range of structural, neurodegenerative, demyelinating, vascular, and inflammatory conditions affecting the CNS and PNS. Their pathophysiology involves neuronal injury, demyelination, excitotoxicity, neuroinflammation, oxidative stress, and protein aggregation, resulting in cognitive, motor, sensory, and autonomic deficits.
A comprehensive understanding of these mechanisms enables early diagnosis, targeted therapy, and rehabilitation. Integrative strategies, including yoga, pranayama, and lifestyle optimization, complement conventional medical management, promoting neuroprotection, functional recovery, and holistic well-being.
Summary Table: Selected Nervous System Disorders and Key Pathophysiology
| Disorder | Primary Pathophysiology | Clinical Manifestation |
| Alzheimer’s Disease | Amyloid plaques, tau tangles, cholinergic deficit | Memory loss, cognitive decline |
| Parkinson’s Disease | Dopaminergic neuron loss, Lewy bodies | Bradykinesia, tremor, rigidity |
| Multiple Sclerosis | Autoimmune demyelination, axonal injury | Weakness, spasticity, sensory loss |
| Stroke | Ischemia or hemorrhage, excitotoxicity | Paralysis, sensory deficits, aphasia |
| Peripheral Neuropathy | Axonal degeneration, demyelination | Pain, numbness, weakness |
| Spinal Cord Injury | Mechanical trauma, secondary inflammation | Paralysis, sensory loss, autonomic dysfunction |
| Epilepsy | Hyperexcitable neurons, excitatory/inhibitory imbalance | Seizures, altered consciousness |